Home About us Events Media data Subscribe Links News Email alert Search Contact us Blog  
Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
  
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 		 
 
 

A New Era for Plant-Based Medicines

Historically, plants have been a major source for pharmaceutical compound creation, but now new plant-derived avenues for recombinant DNA technologies are coming to the fore, as Frédéric Bourgaud at Plant Advanced Technologies explains.

Frédéric Bourgaud (September 2011)

Keywords: Historically, plants have been a major source for pharmaceutical compound creation, but now new plant-derived avenues for recombinant DNA technologies are coming to the fore, as Frédéric Bourgaud at Plant Advanced Technologies explains.

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |